logomg.png
Open an Account
Open an Account

  • SENSEX

    {{sensexData[0].price}} (+{{sensexData[0].change}}%)

  • SENSEX

    {{sensexData[0].price}} ({{sensexData[0].change}}%)

  • NIFTY 50

    {{niftyData[0].open_price}} (+{{niftyData[0].change}}%)

  • NIFTY 50

    {{niftyData[0].open_price}} ({{niftyData[0].change}}%)

  • {{mcxData[2].symbol}}

    {{mcxData[2].price}} (+{{mcxData[2].PerChange}}%)

  • {{mcxData[2].symbol}}

    {{mcxData[2].price}} ({{mcxData[2].PerChange}}%)

  • {{mcxData[0].symbol}}

    {{mcxData[0].price}} (+{{mcxData[0].PerChange}}%)

  • {{mcxData[0].symbol}}

    {{mcxData[0].price}} ({{mcxData[0].PerChange}}%)

  • {{mcxData[1].symbol}}

    {{mcxData[1].price}} (+{{mcxData[1].PerChange}}%)

  • {{mcxData[1].symbol}}

    {{mcxData[1].price}} ({{mcxData[1].PerChange}}%)

  • {{mcxData[3].symbol}}

    {{mcxData[3].price}} (+{{mcxData[3].PerChange}}%)

  • {{mcxData[3].symbol}}

    {{mcxData[3].price}} ({{mcxData[3].PerChange}}%)

Sudeep Pharma Ltd Back
Registered Office:
129/1/A GIDC Estate Nandesari,, Vadodara - 391340, Gujarat, India. Phone : +91 265 284 0656/329 1354   Fax:
Email :
Website :
Initial public offer of up to [*] equity shares of face value of Re. 1/- each ("Equity Shares") of Sudeep Pharma Limited ("Company") for cash at a price of Rs. [*] per equity share (Including a Share Premium of Rs. [*] per Equity Share) ("Offer Price") aggregating up to Rs. [*] crores comprising a fresh issue of up to [*] equity shares of face value of Re. 1/- aggregating up to Rs. 95.00 crores by the company ("Fresh Issue") and an offer for sale of up to 13,490,726 equity shares of face value of Re. 1/- aggregating up to Rs. [*] crores ("Offered Shares") by the selling shareholders, consisting of up to 3,567,670 equity shares of face value of Re. 1/- aggregating up to Rs. [*] crores by Sujit Jaysukh Bhayani*, up to 8,418,856 equity shares of face value of Re. 1/- aggregating up to Rs. [*] crores by Sujeet Jaysukh Bhayani HUF, up to 750,000 equity shares of face value of Re. 1/- aggregating up to Rs. [*] crores by Shanil Sujit Bhayani** and up to 754,200 equity shares of face value of Re.1/- aggregating up to Rs.[*] crores by Avani Sujit Bhayani** (Collectively "the Selling Shareholders") and such equity shares offered by the selling shareholders ("Offer for Sale", and together with the fresh issue, the "Offer"). The company, in consultation with the brlms, may consider an issue of specified securities aggregating up to Rs. 19.00 crores, as may be permitted under applicable law, prior to filing of the ("pre-ipo placement"). The pre-ipo placement, if undertaken, will be at a price to be decided by the company, in consultation with the brlms. If the pre-ipo placement is completed, the amount raised pursuant to the pre-ipo placement will be reduced from the fresh issue, subject to compliance with Rule 19(2)(b) of the securities contracts (Regulation) Rules, 1957, as amended. The pre-ipo placement, if undertaken, shall not exceed 20% of the size of the fresh issue. Prior to the completion of the offer, the company shall appropriately intimate the subscribers to the pre-ipo placement, prior to allotment pursuant to the pre-ipo placement, that there is no guarantee that the company may proceed with the offer or the offer may be successful and will result into listing of the equity shares on the stock exchanges. Further, relevant disclosures in relation to such intimation to the subscribers to the pre-ipo placement (if undertaken). The face value of equity shares is Re. 1/- each. the offer price is [*] times the face value of the equity shares. Price Band: Rs. 563 to Rs. 593 per equity share of face value of Rs. 1 each. The floor price is 563 times the face value of the equity shares and the cap price is 593 times the face value of the equity shares. Bids can be made for a minimum of 25 equity shares and in multiples of 25 equity shares thereafter.
Issue
Opens On Closes On
21-Nov-25 25-Nov-25
Money Payable On
Application Allotment
563.00 0.00
Minimum Application for shares in Nos : 25 Further Multiples of : 25
(₹)(Cr.) Lead Managers to the Issue
Project Cost (₹) 0.00 ICICI Securities Limited
Project Financed through Current Offer (₹) 854.53  
Post Issue Equity Share Capital (₹) 11.29  
Issue Price (₹) 563.00  
Projects
Capital expenditure towards procurement of machinery for our production line located at Nandesari Facility I
General corporate purposes
Promoted By
Sujit Jaysukh Bhayani
Avani Sujit Bhayani
Shanil Sujit Bhayani
Listing At
BSE
NSE
Registrar to the Issue

Mandatory Dematerialization for Transfer of Securities, w.e.f 5th December 2018. Refer to SEBI notification number SEBI/LAD-NRO/GN/2018/24 dated June 08,2018.

Update/Link your Aadhaar Number with your Demat Account by Submitting a photocopy of Aadhaar card along with a request letter/Modification form.

Prevent Unauthorised transactions in your account. Update your mobile numbers/email IDs with your stock brokers.

KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.

No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorize your bank to make payment in case of allotment.

Prevent Unauthorized Transactions in your demat account. Update your Mobile Number with your Depository Participant. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from CDSL on the same day....... Issued in the interest of investors.

Prevent unauthorized transactions in your trading account ->Update your mobile numbers/email IDs with your stock brokers. Receive information/alerts of your transactions directly from Exchange on your mobile/email at the end of the day.... Issued in the interest of investors.

Filing Complaints on SCORES - Easy & quick.
a. Register on SCORES portal (https://scores.sebi.gov.in),
b. Provide mandatory details for filing complaints on SCORES like name, PAN, address, mobile number, email ID.
c. Benefits:
   i. Effective communication
   ii. Speedy redressal of the grievances

Investor Awareness regarding the revised guidelines on margin collection

 

Dear Investor,

As you are aware, under the rapidly evolving dynamics of financial markets, it is crucial for investors to remain updated and well-informed about various aspects of investing in securities market. In this connection, please find a link to the BSE Investor Protection Fund website where you will find some useful educative material in the form of text and videos, so as to become an informed investor.

https://www.bseipf.com/investors_education.html

We believe that an educated investor is a protected investor !!!

 

Risk Disclosure on Derivatives

  • out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:
SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

MAGNUM EQUITY BROKING LTD.

SEBI Registration No.: INZ000172031 NSE Member ID: 06529 | BSE Clearing No.:126 | CDSL SEBI Registration No. IN-DP-CDSL-201-2003
DP ID: 12029700 | CIN: U67120MH1996PLC103441

Investor Grievances: grievances@magnum.co.in

Copyright © 2018-2019 Magnum Equity Broking Ltd. All rights reserved

Designed, Developed & Powered by CMOTS Infotech (ISO 9001:2015 Certified)